Table 2 Frequency of p42.3 gene expression in gliomas identified by mRNA in situ hybridization a
From: Differential expression of p42.3 in low- and high-grade gliomas
Tumor type (histological grade) | p42.3 expression (%) | Sex | Age <50 yr, n | Age ≥50 yr, n | Total ( N) |
|---|---|---|---|---|---|
Astrocytoma (grade 2) | Positive (15.9%) | Male | 5 | 1 | 6 |
Female | 4 | 0 | 4 | ||
Negative (84.1%) | Male | 30 | 4 | 34 | |
Female | 18 | 1 | 19 | ||
OD (grade 2) | Positive (9.52%) | Male | 1 | 0 | 1 |
Female | 1 | 0 | 1 | ||
Negative (80.48%) | Male | 10 | 4 | 14 | |
Female | 4 | 1 | 5 | ||
OA (grade 2) | Positive (12.5%) | Male | 1 | 0 | 1 |
Female | 1 | 0 | 1 | ||
Negative (87.5%) | Male | 4 | 5 | 9 | |
Female | 4 | 1 | 5 | ||
Anaplastic OA (grade 3) | Positive (30.0%) | Male | 0 | 1 | 1 |
Female | 2 | 0 | 2 | ||
Negative (70.0%) | Male | 5 | 0 | 5 | |
Female | 2 | 0 | 2 | ||
GBM (grade 4) | Positive (36.5%) | Male | 9 | 5 | 14 |
Female | 4 | 1 | 5 | ||
Negative (63.5%) | Male | 13 | 10 | 23 | |
Female | 6 | 4 | 10 |